Ani Pharmaceuticals reported $285.88M in Loan Capital for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Aerie Pharmaceuticals AERI:US USD 312.59M 458K
Ani Pharmaceuticals ANIP:US USD 285.88M 213K
Aurora Cannabis Inc ACB:CN CAD 286.06M 49.58M
Canopy Growth Corp WEED:CN CAD 1.12B 239.18M
Eli Lilly And LLY:US USD 14.14B 548.2M
Endo International Ordinary Shares ENDP:US USD 1.42M 8.05B
Hikma Pharmaceutical HIK:LN USD 1.41B 689M
Knight Therapeutics Inc GUD:CN CAD 11.62M 239K
Lannett LCI:US USD 619.34M 4.39M
Novartis NVS:US USD 21.24B 2.55B
Omeros OMER:US USD 439.82M 125.46M
Perrigo Ordinary Shares PRGO:US USD 4.08B 8.6M
Teva Pharmaceutical TEVA:IT USD 18.5B 1.87B
Teva Pharmaceutical Industries TEVA:US USD 18.5B 1.87B